Partner Technologies
How we work with technology partners
Auralis brings partner technologies to European markets in two ways, depending on the product and its commercial stage.
Two ways to work together
Direct distribution
- For selected manufacturers
- Auralis is the direct distributor in European markets
- We manage procurement, logistics and customer relationships for the partner
Example: Maverick16 qPCR system by Hecin Scientific.
Fractional commercial partner
- For other platforms, without taking on distribution
- We find and approach the right distributors, research institutions and industry buyers
- We support scientific marketing
- We build the commercial setup needed for European market entry
Examples: EliChip, Pauling.AI and NAMina Bio.
In both models, Auralis brings scientific credibility, established European networks and a commercial approach built for the life science buying cycle. If your technology could fit either model, contact us to discuss fit.
Partners
Direct distributionHecin Scientific
Chinese manufacturer of molecular diagnostics instruments. Auralis is the EU distributor of the Maverick16 ultra-compact qPCR system, supplied for Research Use Only (RUO) in the EU.
Fractional commercial partnerEliChip - Trustech Diagnostics
Portable microfluidic immunodiagnostic platform delivering ELISA-grade quantitative results outside the centralized laboratory. 20 µL sample input, pg/mL sensitivity, TRL-7, tested in EU Horizon programs. Auralis supports commercialization and partner access through the Early Adopter Program.
Fractional commercial partnerPauling.AI
Represented in the EU by Auralis as its fractional commercial partner. US autonomous drug discovery platform, developed by a team with backgrounds in Google and Mayo Clinic, that runs docking, molecular dynamics, free energy and ADMET campaigns starting from a protein target. Results in days instead of months, without in-house infrastructure or CRO queues.
Fractional commercial partner · US market routeNAMina Bio
Represented in the EU by Auralis as its fractional commercial partner. US ecosystem for human-relevant preclinical research, connecting organ-on-chip platforms, 3D and tumoroid models, AI-based assay confidence tools and translational expertise. Auralis is also the European point of connection into the NAMina ecosystem and a route to the US market for European developers of human-relevant preclinical technologies.
Have a technology that fits?
Tell us about your technology and your target market. We reply within 2 working days.